Veerhealth Care
BSE: VEERHEALTH · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Veerhealth Care's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Veerhealth Care Limited is an Indian manufacturer specialising in Ayurvedic and cosmetic products, including oral and personal care solutions. The company operates a GMP-compliant facility in Gujarat and serves both domestic and international markets.
Business Model
The company generates revenue through the sale of its own branded consumer goods and by providing contract manufacturing services for third-party clients.
Management Commentary
Management is currently prioritising the expansion of the company's export footprint and the enhancement of production capacities to capitalise on the growing demand for natural consumer goods.
Growth Outlook
Growth is expected to be driven by the scaling of export operations and the strategic upgrade of manufacturing facilities to meet the rising demand for herbal and natural wellness products.
Key Risks
- Market Competition. The company faces intense competition from established FMCG players in the Indian oral and personal care market.
- Regulatory Compliance. Changes in manufacturing standards or Ayurvedic product regulations could impact operational costs and product approvals.
- Input Cost Volatility. Fluctuations in the prices of raw materials and herbal ingredients may affect profit margins.
- Export Dependency. Expansion into international markets introduces risks related to geopolitical stability and varying regulatory requirements across different countries.
Start your research today
Unlock AI insights, financials, peers and live data on Veerhealth Care and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Veerhealth CareVEERHEALTH | ₹100 Cr | — | — | — | 7.6% | — | — | +170.1% |
TranschemTRANSCHEM | ₹502 Cr | 75.62 | 52.99 | -100.0% | 177.7% | 8.3% | 10.6% | +600.8% |
Albert DavidALBERTDAVD | ₹501 Cr | 21.67 | 13.19 | 11.4% | 11.0% | 5.8% | 7.5% | +10.3% |
Haleos Labs LimitedHALEOSLABS | ₹457 Cr | 28.51 | 12.83 | -3.1% | 13.6% | 7.4% | 10.3% | — |
Medicamen BiotecMEDICAMEQ | ₹434 Cr | 43.00 | 19.76 | 24.7% | 11.3% | 4.1% | 6.2% | +5.9% |
Jenburkt Pharmaceuticals LimitedJENBURPH | ₹420 Cr | 12.30 | 8.20 | — | 30.0% | 16.7% | 21.5% | -15.2% |
As of Mar 2026
Financials
Veerhealth Care
BSE: VEERHEALTH · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Veerhealth Care's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Veerhealth Care Limited is an Indian manufacturer specialising in Ayurvedic and cosmetic products, including oral and personal care solutions. The company operates a GMP-compliant facility in Gujarat and serves both domestic and international markets.
Business Model
The company generates revenue through the sale of its own branded consumer goods and by providing contract manufacturing services for third-party clients.
Management Commentary
Management is currently prioritising the expansion of the company's export footprint and the enhancement of production capacities to capitalise on the growing demand for natural consumer goods.
Growth Outlook
Growth is expected to be driven by the scaling of export operations and the strategic upgrade of manufacturing facilities to meet the rising demand for herbal and natural wellness products.
Key Risks
- Market Competition. The company faces intense competition from established FMCG players in the Indian oral and personal care market.
- Regulatory Compliance. Changes in manufacturing standards or Ayurvedic product regulations could impact operational costs and product approvals.
- Input Cost Volatility. Fluctuations in the prices of raw materials and herbal ingredients may affect profit margins.
- Export Dependency. Expansion into international markets introduces risks related to geopolitical stability and varying regulatory requirements across different countries.
Start your research today
Unlock AI insights, financials, peers and live data on Veerhealth Care and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Mar 2026